Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Mc Ardle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Canadian Journal of Cardiology|February 27, 2013
Myocardial viability: whom, what, why, which, and how?Brian A Mc Ardle, Rob S B Beanlands
Seminars in Nuclear Medicine|September 20, 2014
Myocardial viability: it is still aliveSiok P Lim, Brian A Mc Ardle, Rob S Beanlands, et al.
Journal of the American College of Cardiology|October 9, 2012
Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysisBrian A Mc Ardle, Taylor F Dowsley, Robert A deKemp, et al.
Pacing and Clinical Electrophysiology : PACE|October 10, 2013
Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardiaPablo B Nery, Brian A Mc Ardle, Calum J Redpath, et al.
Circulation. Cardiovascular Imaging|July 26, 2013
Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?Brian A Mc Ardle, David H Birnie, Ran Klein, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 31, 2017
Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesityDavid T Harnett, Samir Hazra, Ronnen Maze, et al.
Circulation. Cardiovascular Imaging|September 4, 2014
Prognostic value of rubidium-82 positron emission tomography in patients after heart transplantBrian A Mc Ardle, Ross A Davies, Li Chen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Canadian Journal of Cardiology|February 27, 2013
Myocardial viability: whom, what, why, which, and how?Brian A Mc Ardle, Rob S B Beanlands
Seminars in Nuclear Medicine|September 20, 2014
Myocardial viability: it is still aliveSiok P Lim, Brian A Mc Ardle, Rob S Beanlands, et al.
Journal of the American College of Cardiology|October 9, 2012
Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysisBrian A Mc Ardle, Taylor F Dowsley, Robert A deKemp, et al.
Pacing and Clinical Electrophysiology : PACE|October 10, 2013
Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardiaPablo B Nery, Brian A Mc Ardle, Calum J Redpath, et al.
Circulation. Cardiovascular Imaging|July 26, 2013
Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?Brian A Mc Ardle, David H Birnie, Ran Klein, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 31, 2017
Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesityDavid T Harnett, Samir Hazra, Ronnen Maze, et al.
Circulation. Cardiovascular Imaging|September 4, 2014
Prognostic value of rubidium-82 positron emission tomography in patients after heart transplantBrian A Mc Ardle, Ross A Davies, Li Chen, et al.
Pageof 1